by McKesson Ventures | Nov 3, 2017 | Portfolio News
Only a few months after GRAIL raised a record-breaking $900 million in its Series B funding round, the company is looking for further funding. Focused on early cancer detection, GRAIL also raised $100 million last year to develop its blood testing technology. The...
by McKesson Ventures | Nov 3, 2017 | Portfolio News
A recent study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, uncovered some important data regarding mutations and cancer treatment. The study, performed by Funda Meric-Bernstam, MD, of the Institute for Personalized...
by McKesson Ventures | Aug 22, 2017 | Portfolio News
In the UK, more than 350,000 new cases of cancer were diagnosed in 2014, and there were 163,444 deaths from cancer. Nonetheless, the outlook for cancer patients is looking better, thanks to major advances in drug development, genomics, and immunotherapy. One example...
by McKesson Ventures | Aug 19, 2017 | Portfolio News
As the promises of genomics are starting to come to fruition, hospitals need to start preparing for the changes genomics will bring to health care. Thousands of Americans are being treated, or are changing their treatments, based on information from genome testing....
by McKesson Ventures | Jul 29, 2017 | Portfolio News
It’s no surprise that the healthcare sector is full of executives with health-related backgrounds. A 2011 study of CEOs at the best hospitals in the US found that most CEOs specialized in cardiovascular care, cancer, and digestive disorders. And according to the...
